Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2024-11-06 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report for movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to compliance with listing rules on the Hong Kong Stock Exchange. It includes data on share consolidation, share options, and confirmations by the company secretary. The document is structured as a regulatory compliance filing related to share capital movements rather than a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data, nor is it an announcement of voting results or AGM materials. The content aligns with disclosures about share capital changes and confirmations required by the exchange, which fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is the report itself, not just an announcement of a report.
2024-11-06 English
EFFECTIVE DATE OF THE CAPITAL REORGANISATION AND FREE EXCHANGE OF SHARE CERTIFICATES
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the effective date of a capital reorganisation and the free exchange of share certificates. It references previous circulars and announcements related to capital reorganisation, loan capitalisation, and timetable updates. The document also mentions the suspension of trading pending the publication of financial results. The content focuses on corporate actions related to capital structure changes, such as capital reduction, share subdivision, and loan capitalisation, rather than presenting financial results or detailed financial statements. It is not a full financial report, earnings release, or management discussion. The document is an update on capital restructuring activities and related procedural matters, which fits the category of Capital/Financing Update (CAP). The document length (6204 characters) and detailed content about capital reorganisation support this classification rather than a brief announcement or a regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2024-11-05 English
FURTHER UPDATE ON THE CAPITAL REORGANISATION AND REVISED EXPECTED TIMETABLE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding updates on a capital reorganisation, including the receipt of a Cayman Court order confirming capital reduction and share subdivision, and a revised expected timetable for these corporate actions. It references previous circulars and announcements but does not contain detailed financial statements or comprehensive financial data. The document is relatively short (4633 characters) and serves to inform shareholders and the market about the progress and timing of capital restructuring events. It does not present a full report such as an annual or interim report, nor is it a proxy solicitation or voting result announcement. The content fits the category of a Capital/Financing Update as it relates to changes in the company's capital structure and timetable for implementation.
2024-10-31 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report for Sinopharm Tech Holdings Limited, covering movements in authorised and issued share capital, share options, and confirmations related to compliance with listing rules. It includes specific data on share consolidation, share options outstanding, and confirmations pursuant to Hong Kong Stock Exchange rules. The document is structured as a regulatory submission to the Hong Kong Exchanges and Clearing Limited, focusing on share capital changes and compliance confirmations rather than financial performance, earnings, or management commentary. It does not contain financial statements or earnings data, nor is it an announcement of a report publication. The content aligns with disclosures about share capital movements and confirmations required by listing rules, which fits the category of Share Issue/Capital Change (SHA).
2024-10-07 English
UPDATE ON THE CAPITAL REORGANISATION AND REVISED EXPECTED TIMETABLE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding an update on the capital reorganisation and a revised expected timetable. It references a previous circular and details dates related to capital reduction, share subdivision, and share certificate exchanges. The document is relatively short (4378 characters) and serves as an update or notice rather than a full financial report or detailed filing. It does not contain financial statements or detailed analysis but provides information about capital structure changes and procedural timelines. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-10-04 English
INSIDE INFORMATION (1) DELAY IN PUBLICATION OF 2024 ANNUAL RESULTS AND DESPATCH OF ANNUAL REPORT 2024&#x3b; AND (2) SUSPENSION OF TRADING
Regulatory Filings Classification · 95% confidence The document is an announcement by Sinopharm Tech Holdings Limited regarding a delay in the publication of its 2024 Annual Results and the despatch of its 2024 Annual Report. It also announces the suspension of trading pending the publication of these results. The text references specific regulatory rules (GEM Listing Rules) and provides expected new timelines for the audit completion and report publication. The document does not contain the actual annual results or the full annual report itself, but rather informs stakeholders about the delay and related trading suspension. The document length is 5481 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the delay and suspension, not the actual annual report or financial results.
2024-10-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.